NCT04426006View on ClinicalTrials.gov

Serological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergonié in the Context of the COVID-19 Pandemic

NACompletedINTERVENTIONAL
Enrollment

526

Participants

Timeline

Start Date

June 18, 2020

Primary Completion Date

January 26, 2021

Study Completion Date

October 4, 2021

Conditions
Sars-CoV2Serum; Disease
Interventions
OTHER

PRO-SERO-COV

"At inclusion, 3 months and 12 months :~* blood sample (2 x 5ml)~* self-administered questionnaire"

Trial Locations (1)

33076

Institut Bergonié, Bordeaux

Sponsors

Lead Sponsor

Institut Bergonié
All Listed Sponsors
lead

Institut Bergonié

OTHER